Median Technologies SA (EPA:ALMDT)
4.140
-0.185 (-4.28%)
At close: Jan 30, 2026
Median Technologies Company Description
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally.
The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imaging Lab.
Also, the company focuses on the oncology clinical trials market and the cancer patient care market. The company was founded in 2002 and is based in Valbonne, France.
Median Technologies SA

| Country | France |
| Founded | 2002 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 211 |
| CEO | Fredrik Brag |
Contact Details
Address: 1800, Route des CrEtes Valbonne, 06560 France | |
| Phone | 33 4 93 33 37 77 |
| Website | mediantechnologies.com |
Stock Details
| Ticker Symbol | ALMDT |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0011049824 |
| SIC Code | 7373 |
Key Executives
| Name | Position |
|---|---|
| Fredrik Brag | Founder, GM, Chief Executive Officer and Director |
| Jean-Christophe Montigny | Chief Financial Officer |
| Emmanuelle Leygues | Vice President of Corporate Marketing and Financial Communications |
| Chrystel Brun | Chief Human Resources Officer |
| Nicolas Dano | Chief Operating Officer and Chief Commercial Officer of iCRO |
| Thomas Bonnefont | Chief Operating Officer and Chief Commercial Officer ? eyonis? Business Unit |